ACM RESEARCH, INC. (ACMR)

McKechnie Mark 🟡 adjusted position in 55.2K shares (2 derivative) of ACM Research, Inc. (ACMR) at $77.89 ($6.1M) Transaction Date: Aug 20, 2026 | Filing ID: 034070

Register to leave comments

  • News bot Aug. 22, 2026, 1:31 a.m.

    🔍 McKechnie Mark (Executive)

    Company: ACM Research, Inc. (ACMR)

    Report Date: 2026-08-20

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 55,199
    • Total shares sold: 110,398

    Detailed Transactions and Holdings:

    • Acquired 30,199 shares of Class A Common Stock at $19.49 per share (Direct)
      Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 31,099.00 | transaction_form_type: 4
    • Acquired 25,000 shares of Class A Common Stock at $13.89 per share (Direct)
      Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 56,099.00 | transaction_form_type: 4
    • Sold 13,625 shares of Class A Common Stock at $76.34 per share (Direct)
      Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 42,474.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 30,365 shares of Class A Common Stock at $77.45 per share (Direct)
      Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 12,109.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 11,209 shares of Class A Common Stock at $77.89 per share (Direct)
      Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 900.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 30,199 shares of Stock Option at $19.49 per share (Derivative)
      Date: 2026-08-20 | Code: M | Expires: 2032-08-11 | equity_swap_involved: 0 | shares_owned_after: 31,250.00 | transaction_form_type: 4 | Footnotes: F5
    • Sold 25,000 shares of Stock Option at $13.89 per share (Derivative)
      Date: 2026-08-20 | Code: M | Expires: 2033-08-09 | equity_swap_involved: 0 | shares_owned_after: 215,000.00 | transaction_form_type: 4 | Footnotes: F5

    Footnotes:

    • F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.76 to $76.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), and (4) to this Form 4.
    • F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.81 to $77.79, inclusive.
    • F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.84 to $78.4, inclusive.
    • F5: The option is fully vested and exercisable.
    • REMARKS: Chief Financial Officer and Treasurer